Cognition Therapeutics (CGTX) Enterprise Value (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Enterprise Value of -$31.1 million for Q1 2026, down 89.49% year-over-year from -$296.3 million in Q1 2025, and up 15.43% quarter-over-quarter from -$36.8 million in Q4 2025.
Cognition Therapeutics (CGTX) Enterprise Value (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Enterprise Value for 7 consecutive years, with -$31.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 89.49% year-over-year to -$31.1 million; the TTM figure through Mar 2026 stood at -$31.1 million (down 89.49% YoY), while the FY2025 annual figure was -$36.8 million, down 47.19% from the prior year.
- Enterprise Value rose to -$31.1 million in Q1 2026 per CGTX's latest filing, from -$36.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.7 million in Q2 2025 and bottomed at -$51.5 million in Q1 2022.
- Historically, Enterprise Value has averaged -$33.5 million across 5 years, with a median of -$34.7 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 461.57% — and 2025, when it soared 62.35%.
- Cognition Therapeutics' Enterprise Value stood at -$41.6 million in 2022, then rose by 28.01% to -$29.9 million in 2023, then advanced by 16.42% to -$25.0 million in 2024, then slumped by 47.19% to -$36.8 million in 2025, then increased by 15.43% to -$31.1 million in 2026.
- Business Quant data shows CGTX's Enterprise Value at -$31.1 million in Q1 2026, -$36.8 million in Q4 2025, and -$39.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 2.12 Bn |
| 10 | Cognition Therapeutics | 89.81 Mn | 89.81 Mn | - | -34.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.01 Mn |
| Mar 31, 2026 | -31.13 Mn |
| Dec 31, 2025 | -36.81 Mn |
| Sep 30, 2025 | -39.33 Mn |
| Jun 30, 2025 | -10.74 Mn |
| Mar 31, 2025 | -16.43 Mn |
| Dec 31, 2024 | -25.01 Mn |
| Sep 30, 2024 | -22.01 Mn |
| Jun 30, 2024 | -28.53 Mn |
| Mar 31, 2024 | -34.67 Mn |
| Dec 31, 2023 | -29.92 Mn |
| Sep 30, 2023 | -32.97 Mn |
| Jun 30, 2023 | -37.19 Mn |
| Mar 31, 2023 | -38.81 Mn |
| Dec 31, 2022 | -41.56 Mn |
| Sep 30, 2022 | -46.61 Mn |
| Jun 30, 2022 | -45.77 Mn |
| Mar 31, 2022 | -51.51 Mn |
| Dec 31, 2021 | -54.72 Mn |
| Sep 30, 2021 | -8.30 Mn |